Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2015 10:17 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Announces Planned Start of Phase I Investigator-Initiated Trial of Plinabulin Plus Nivolumab, Enters Immuno-Oncology Space

NEW YORK, Sept. 15, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
September 01, 2015 09:16 ET | Source: BeyondSpring Pharmaceuticals

Data Supporting BeyondSpring's Lead Asset, Plinabulin, to be Presented at WCLC 2015

NEW YORK, Sept. 1, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
August 31, 2015 09:31 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring to Present Two Posters Supporting Plinabulin at WCLC 2015

NEW YORK, Aug. 31, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
March 23, 2015 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications

NEW YORK, March 23, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
February 24, 2015 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Files Composition of Matter Patent Application for Plinabulin Combination Therapy in Immuno-Oncology

NEW YORK, Feb. 24, 2015 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...
December 09, 2014 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals Names Dr. Yan Sun as Principal Investigator for Global Phase 3 Lung Cancer Clinical Trial of Plinabulin

NEW YORK, Dec. 9, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, announced that...
December 03, 2014 08:30 ET | Source: BeyondSpring Pharmaceuticals

BeyondSpring Pharmaceuticals to Conduct Phase 3 Trial of Lead Candidate Plinabulin in NSCLC

NEW YORK, Dec. 3, 2014 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced...